Podcast

Pharmacy Focus - Alternative Career Paths in PBMs

Matt Gibbs, president of Capital Rx, discusses alternative career paths in independently owned PBMs.

In this week’s episode, we spoke with Matt Gibbs, president of Capital Rx, to discuss alternative career paths in independently owned PBMs.

Related Videos
TRUST-I and TRUST-II Trials Show Promising Results for Taletrectinib in ROS1+ NSCLC
Pharmacist assists senior woman in buying medicine in pharmacy - Image credit: Drazen | stock.adobe.com
World Standards Week 2024: US Pharmacopeia’s Achievements and Future Focus in Pharmacy Standards
Pharmacists working in a pharmacy -- Image credit: Drazen | stock.adobe.com
Image Credit: © Krakenimages.com - stock.adobe.com
Young female pharmacist working in her large pharmacy. Placing medications, taking inventory. Lifestyle - Image credit: lubero | stock.adobe.com
WCLC, lung cancer, NSCLC
MARIPOSA Study: Long-Term Outcomes and Next Steps for Amivantamab Plus Lazertinib in EGFR-Mutant NSCLC
Pharmacist helping patient -- Image credit: Clayton D/peopleimages.com | stock.adobe.com
The EMPOWER-Lung 1 Trial: Five-Year Outcomes of Cemiplimab Monotherapy in Advanced NSCLC
Related Content
Vial with pneumococcal disease vaccine and syringe for injection.
October 21st 2024

Pneumococcal 21-Valent Conjugate Vaccine Generates Positive Response in Adults at Increased Risk of Disease

Luke Halpern, Assistant Editor
Pharmacy Focus - Oncology Edition: Advancing Brain Cancer Research and Treatment
September 26th 2024

Pharmacy Focus - Oncology Edition: Advancing Brain Cancer Research and Treatment

Child with asthma in hospital using inhaler -- Image credit: LIGHTFIELD STUDIOS | stock.adobe.com
October 21st 2024

Medicaid ACOs Associated With Persistent Insurance-Based Disparities in Routine Pediatric Asthma Visit Rates

Gillian McGovern, Assistant Editor
Public Health Matters podcast logo
September 19th 2024

Public Health Matters: The Difference Between Misinformation and Disinformation, and How Information Can Inform Evidence-Based Decisions

Image Credit: © Jasmine - stock.adobe.com
October 21st 2024

Momelotinib Demonstrates Efficacy, Safety Compared With Ruxolitinib for Treatment of Myelofibrosis

Alexandra Gerlach, Associate Editor
Celebrating Unique Pharmacist Career Paths That Drive Innovation
October 21st 2024

Celebrating Unique Pharmacist Career Paths That Drive Innovation

Allison Arant